![Douglas Carr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Carr
Director of Finance/CFO at
CENTURY THERAPEUTICS, INC.
Net worth: 1 M $ as of 31/05/2026
Profile
Currently, Douglas Carr is Director at Heritage Conservancy, Chief Financial Officer & Secretary at Century Therapeutics, Inc. starting in 2025, and Vice President-Finance at Novira Therapeutics, Inc. since 2018.
Former positions include Business Director-Franchise Division at Zocor Ltd., Controller-Pediatric Vaccines Franchise at Merck & Co., Inc., Financial Controller at Omthera Pharmaceuticals, Inc., and Vice President-Finance & Operations at Century Therapeutics, Inc. Education includes an undergraduate degree from Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2026 | 505,094 ( 0.28% ) | 1 M $ | 31/05/2026 |
Douglas Carr active positions
| Companies | Position | Start |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Director of Finance/CFO | 11/07/2025 |
Novira Therapeutics, Inc. | Corporate Officer/Principal | 01/10/2018 |
Heritage Conservancy
 Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Director/Board Member | - |
Former positions of Douglas Carr
| Companies | Position | End |
|---|---|---|
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Director of Finance/CFO | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Zocor Ltd. | Corporate Officer/Principal | - |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Comptroller/Controller/Auditor | - |
Training of Douglas Carr
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zocor Ltd. | |
Heritage Conservancy
Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Commercial Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Novira Therapeutics, Inc. | Electronic Technology |
- Stock Market
- Insiders
- Douglas Carr
